HomeCompareHYFXY vs MRK

HYFXY vs MRK: Dividend Comparison 2026

HYFXY yields 116182.10% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HYFXY wins by $552108036026.17M in total portfolio value
10 years
HYFXY
HYFXY
● Live price
116182.10%
Share price
$0.00
Annual div
$2.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$552108036026.23M
Annual income
$201,956,408,246,800,480.00
Full HYFXY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HYFXY vs MRK

📍 HYFXY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHYFXYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HYFXY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HYFXY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYFXY
Annual income on $10K today (after 15% tax)
$9,875,478.50/yr
After 10yr DRIP, annual income (after tax)
$171,662,947,009,780,400.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HYFXY beats the other by $171,662,947,009,772,100.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYFXY + MRK for your $10,000?

HYFXY: 50%MRK: 50%
100% MRK50/50100% HYFXY
Portfolio after 10yr
$276054018013.14M
Annual income
$100,978,204,123,405,140.00/yr
Blended yield
36.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HYFXY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYFXY buys
0
MRK buys
0
No recent congressional trades found for HYFXY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHYFXYMRK
Forward yield116182.10%2.76%
Annual dividend / share$2.32$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$552108036026.23M$56.8K
Annual income after 10y$201,956,408,246,800,480.00$9,798.13
Total dividends collected$516788852739.01M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HYFXY vs MRK ($10,000, DRIP)

YearHYFXY PortfolioHYFXY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$5,819,805$5,809,105.00$11,206$366.19+$5.81MHYFXY
2$1,586,033,655$1,579,806,463.76$12,650$502.35+$1586.02MHYFXY
3$202,881,352,371$201,184,296,359.60$14,407$694.19+$202881.34MHYFXY
4$12,242,773,966,280$12,025,690,919,243.82$16,585$967.82+$12242773.95MHYFXY
5$352,204,589,369,063$339,104,821,225,143.00$19,342$1,363.89+$352204589.35MHYFXY
6$4,935,499,681,992,460$4,558,640,771,367,562.00$22,913$1,947.19+$4935499681.97MHYFXY
7$35,131,904,252,020,384$29,850,919,592,288,452.00$27,662$2,823.89+$35131904251.99MHYFXY
8$136,883,193,531,914,130$99,292,055,982,252,300.00$34,159$4,173.35+$136883193531.88MHYFXY
9$327,244,511,943,391,360$180,779,494,864,243,200.00$43,337$6,308.80+$327244511943.35MHYFXY
10$552,108,036,026,229,250$201,956,408,246,800,480.00$56,776$9,798.13+$552108036026.17MHYFXY

HYFXY vs MRK: Complete Analysis 2026

HYFXYStock

Hyflux Ltd provides various solutions in water and energy areas worldwide. The company operates through two segments, Municipal and Industrial. The Municipal segment supplies a range of infrastructure solutions, including water, power, and waste-to-energy to municipalities and governments. The Industrial segment supplies infrastructure solutions for water to industrial customers. The company provides seawater desalination, raw water purification, wastewater cleaning, water recycling, water reclamation, and pure water production services to municipal and industrial clients, as well as to home consumers; and filtration and purification products. It also designs, constructs, owns, operates, and sells water treatment, seawater desalination, wastewater treatment, and water recycling plants under service concession arrangements; and sells oxygen-rich water and related products and services. In addition, the company designs, constructs, owns, operates, and sells power plants and waste-to-energy plants; trades in the electricity markets; and sells retail electricity contracts. Hyflux Ltd was founded in 1989 and is headquartered in Singapore.

Full HYFXY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HYFXY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYFXY vs SCHDHYFXY vs JEPIHYFXY vs OHYFXY vs KOHYFXY vs MAINHYFXY vs JNJHYFXY vs ABBVHYFXY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.